Parkville, Victoria, Australia; formerly Commonwealth Serum Labs., Ltd.; parent of ZLB Behring AG and Chesapeake Biological Labs; originally founded in 1916 by the Australian government, CSL completed its transition to a private corporation in 1994; CSL has been Australia’s national fractionator of plasma-derived therapeutics since 1952.
